Gefitinib versus cetuximab in lung cancer: Round one

John D. Minna; Michael J. Peyton; Adi F. Gazdar

doi:10.1093/jnci/dji247

Gefitinib versus cetuximab in lung cancer: Round one

John D. Minna, Michael J. Peyton, Adi F. Gazdar

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1168-1169
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	97
Issue number	16
DOIs	https://doi.org/10.1093/jnci/dji247
State	Published - Aug 2005

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/dji247

Cite this

@article{781ffb5372a84c53a215fa254d57b7ec,

title = "Gefitinib versus cetuximab in lung cancer: Round one",

author = "Minna, {John D.} and Peyton, {Michael J.} and Gazdar, {Adi F.}",

year = "2005",

month = aug,

doi = "10.1093/jnci/dji247",

language = "English (US)",

volume = "97",

pages = "1168--1169",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "16",

}

TY - JOUR

T1 - Gefitinib versus cetuximab in lung cancer

T2 - Round one

AU - Minna, John D.

AU - Peyton, Michael J.

AU - Gazdar, Adi F.

PY - 2005/8

Y1 - 2005/8

UR - http://www.scopus.com/inward/record.url?scp=23844508512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844508512&partnerID=8YFLogxK

U2 - 10.1093/jnci/dji247

DO - 10.1093/jnci/dji247

M3 - Editorial

C2 - 16106015

AN - SCOPUS:23844508512

SN - 0027-8874

VL - 97

SP - 1168

EP - 1169

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 16

ER -

Gefitinib versus cetuximab in lung cancer: Round one

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this